Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Research programme: spinal muscular atrophy therapeutics - Lexicon Pharmaceuticals

Drug Profile

Research programme: spinal muscular atrophy therapeutics - Lexicon Pharmaceuticals

Alternative Names: SMN protein activators - Lexicon

Latest Information Update: 25 Nov 2014

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Lexicon Genetics
  • Developer Lexicon Pharmaceuticals
  • Class
  • Mechanism of Action Survival of motor neuron 1 protein stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Spinal muscular atrophy

Most Recent Events

  • 27 Nov 2008 No development reported - Preclinical for Spinal muscular atrophy in USA (unspecified route)
  • 27 Apr 2007 Lexicon Genetics is now called Lexicon Pharmaceuticals
  • 13 Oct 2006 Lexicon has been awarded an additional grant from the US Army and Medical Research and Material Command for the development of drugs to prevent or treat Spinal muscular atrophy
Restricted Access

If your organization has a subscription then there are several options available to help you access AdisInsight while working remotely. Contact us at AsktheExpert.AdisInsight@springer.com to find out more.
Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top